EurekAlert! News by Subject: Medicine & Health - Home

Medicine & Health

Updates every hour. Last Updated: 25-Oct-2026 16:15 ET (25-Oct-2026 20:15 GMT/UTC)

New Cochrane gap map highlights big gaps in dengue prevention research

Cochrane
Peer-Reviewed Publication

A new Cochrane evidence and gap map (EGM) has mapped the global research landscape on dengue prevention, finding plenty of research but not enough of it synthesized in ways policymakers can use.

Journal: Cochrane Database of Systematic Reviews

Study shows snapshot of explosion of young people aged under 20 years developing type 2 diabetes

European Association for the Study of Diabetes
Reports and Proceedings

**Note this is an early release from the Annual Meeting of the European Association for the Study of Diabetes [EASD]. Please credit the meeting when using this research**

Type 2 diabetes has traditionally been a disease that has developed mostly in middle-aged and older adults. But new research from the USA to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) shows a sharp increase in the rate of new cases of type 2 diabetes since the turn of the century, which has continued to accelerate in recent years. The study is by Dr Tessa Crume, Colorado School of Public Health, Aurora, CO, USA, and colleagues.

Meeting: Annual Meeting of the European Association for the Study of Diabetes (EASD)

Urban greenery cools cities, yet complicates ozone control

Science China Press
Peer-Reviewed Publication

A new study published in National Science Review reveals the dual effects of urban greenery on compound heat-ozone pollution risks across Northern Hemisphere cities. While urban greening is widely promoted as a nature-based method to cool overheated cities, complex interactions between urban meteorology and atmospheric chemistry can create important trade-offs for ozone control. The findings call for integrated urban greening strategies that jointly enhance climate resilience, air quality, and public health.

Journal: National Science Review

Where are the next drug targets for myopia control? A review charts new directions from atropine to molecular pathways

Eye Discovery
Peer-Reviewed Publication

Myopia has become a major global public health concern. It is not simply a matter of blurred distance vision: as the eye continues to elongate, high myopia can increase the risk of macular lesions, choroidal neovascularization, retinal degeneration, and retinal detachment. With myopia rising among children and adolescents, current management increasingly combines behavioral measures, optical interventions, and pharmacological treatment. While atropine has long been the best-known option, uncovering how these medications work to slow myopia progression is far more complex than expected.

A review titled Pharmacological Management of Myopia: Emerging Agents and Novel Molecular Targets published in Eye Discovery brings together current and emerging pharmacological approaches for myopia control. Written by Tong Zhao of Nanjing Medical University and Meiyan Li of the Eye & ENT Hospital of Fudan University, the article reviews established and investigational agents, including atropine, pirenzepine, 7-methylxanthine (7-MX), and intraocular pressure-lowering drugs. It also discusses emerging molecular targets linked to endoplasmic reticulum stress, ferroptosis, signaling pathway modulation, and epidermal growth factor receptor (EGFR) blockade.

Journal: Eye Discovery
Funder: National Natural Science Foundation of China

New FDA clearance gives PTSD patients more precise, effective treatment options

Texas A&M University
Business Announcement

Precision brain therapy uses new technology to target post-traumatic stress disorder at the source.

FDA clears blood test to aid evaluation for Alzheimer’s disease

Washington University in St. Louis
Business Announcement

The FDA has cleared a blood test developed from technology invented at WashU Medicine to aid in diagnosing Alzheimer’s disease. The test, PrecivityAD2, can detect amyloid plaque biomarkers with over 90% accuracy, offering a less invasive alternative to spinal taps and brain scans.

Study finds food insecurity remains in historically redlined neighborhoods

Texas A&M University
Peer-Reviewed Publication

Bad housing, high crime and poor schools are more important than transportation or income when it comes to accessing healthy food in neighborhoods historically subjected to “redlining” — the now-illegal practice once used to refuse loans, insurance or mortgages to people in certain neighborhoods that were disproportionately inhabited by racial and ethnicity minorities.

That’s the main finding of a study by Sebastian Linde, a health policy expert with the Texas A&M University School of Public Health at Texas A&M Health, and colleagues with the State University of New York at Buffalo on why some neighborhoods have better food options than others.

Journal: Obesity

FAA Executive Physician/Scientist joins UCF aerospace medicine team

UCF College of Medicine
Business Announcement

UCF has recruited Melchor Antuñano, one of the nation’s foremost aerospace medicine experts. After decades leading the Federal Aviation Administration’s (FAA) Civil Aerospace Medical Institute, Antuñano joins the College of Medicine as professor, chief technologist and medical innovation officer.

‘Molecular glue’ turns a cancer driver into a built-in kill switch in Stanford Medicine study

Stanford Medicine
Peer-Reviewed Publication

A lymphoma driver called BCL6 suppresses the expression of cell death genes. A new molecule designed at Stanford Medicine blocks its activity and activates downstream genes to trigger cell death.

Journal: Cell